https://www.taxtmi.com/caselaws?id=105836 Piperazine Hydrate Liquid, being specified in the British Pharmacopoeia, was not treated as a patent or proprietary medicament merely because its label displayed the manufacturer's name, animal symbols, or reference to a trade mark owner. Those particulars were regarded as label disclosures required by drug rules and as house marks, not as a brand name or trade mark used to indicate trade connection in relation to the medicine. The product was therefore classifiable as a non-patent medicament under Chapter Heading 3003.20. en-us Fri, 10 Jul 1998 00:00:00 +0530 Sat, 10 Mar 2012 11:32:59 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=105836 Piperazine Hydrate Liquid, being specified in the British Pharmacopoeia, was not treated as a patent or proprietary medicament merely because its label displayed the manufacturer's name, animal symbols, or reference to a trade mark owner. Those particulars were regarded as label disclosures required by drug rules and as house marks, not as a brand name or trade mark used to indicate trade connection in relation to the medicine. The product was therefore classifiable as a non-patent medicament under Chapter Heading 3003.20. Case-Laws Central Excise Fri, 10 Jul 1998 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=105836